T1	Observation 19 27	Cohort A
T2	Non-query-able 19 27	Cohort A
T3	Procedure 38 45	therapy
T4	Undefined_semantics 38 45	therapy
T5	Temporal 29 37	previous
R1	Has_temporal Arg1:T3 Arg2:T5	
T6	Temporal 46 68	for more than 48 hours
R2	Has_temporal Arg1:T3 Arg2:T6	
T7	Drug 78 131	parenteral antibiotic with activity against S. aureus
T8	Qualifier 100 131	with activity against S. aureus
T9	Observation 122 131	S. aureus
T10	Temporal 132 181	within 72 hours of positive blood culture results
T11	Reference_point 151 181	positive blood culture results
T12	Procedure 160 173	blood culture
T13	Value 151 159;174 181	positive results
R3	Has_value Arg1:T12 Arg2:T13	
R4	Has_index Arg1:T10 Arg2:T11	
T14	Observation 203 211	Cohort B
T15	Non-query-able 203 211	Cohort B
A1	Optional T1
T16	Scope 29 182	previous therapy for more than 48 hours with any parenteral antibiotic with activity against S. aureus within 72 hours of positive blood culture results.
R5	Has_scope Arg1:T1 Arg2:T16	
T17	Temporal 213 221	previous
T18	Procedure 222 229	therapy
T19	Undefined_semantics 222 229	therapy
R6	Has_temporal Arg1:T18 Arg2:T17	
T20	Temporal 230 252	for more than 48 hours
R7	Has_temporal Arg1:T18 Arg2:T20	
T21	Drug 262 310	parenteral antibiotic with activity against MRSA
T22	Qualifier 78 88	parenteral
T23	Qualifier 262 272	parenteral
T24	Qualifier 284 310	with activity against MRSA
T25	Observation 306 310	MRSA
T26	Drug 319 329	vancomycin
T27	Negation 312 318	except
R8	Has_negation Arg1:T26 Arg2:T27	
T28	Drug 337 347	daptomycin
R9	Has_negation Arg1:T28 Arg2:T27	
T29	Temporal 349 398	within 72 hours of positive blood culture results
T30	Reference_point 368 398	positive blood culture results
T31	Value 368 376;391 398	positive results
T32	Procedure 377 390	blood culture
R10	Has_value Arg1:T32 Arg2:T31	
T33	Scope 312 347	except vancomycin and/or daptomycin
R11	Has_temporal Arg1:T33 Arg2:T29	
T34	Condition 447 467	S. aureus bacteremia
T35	Observation 447 456	S. aureus
T36	Qualifier 447 456	S. aureus
T37	Temporal 468 483	within 3 months
R12	Has_temporal Arg1:T34 Arg2:T37	
T38	Condition 495 518	left-sided endocarditis
T39	Qualifier 495 505	left-sided
T40	Device 522 544	prosthetic heart valve
*	OR T38 T40
T41	Condition 550 563	Osteomyelitis
T42	Condition 567 593	prosthetic joint infection
T43	Temporal 601 610	new onset
T44	Qualifier 611 633	nonhardware-associated
T45	Condition 634 657	vertebral osteomyelitis
R13	Has_qualifier Arg1:T45 Arg2:T44	
R14	Has_temporal Arg1:T45 Arg2:T43	
*	OR T41 T42
T46	Negation 594 600	except
R15	Has_negation Arg1:T45 Arg2:T46	
T47	Condition 678 694	hypersensitivity
T48	Condition 698 715	allergic reaction
T49	Drug 723 751	Î²-lactam antibacterial agent
*	OR T47 T48
T50	Scope 678 715	hypersensitivity or allergic reaction
R16	AND Arg1:T50 Arg2:T49	
T51	Observation 663 670	History
R17	Has_temporal Arg1:T50 Arg2:T51	
T52	Condition 781 788;818 828	hepatic impairment
T53	Condition 806 828	immunologic impairment
T54	Condition 790 801;818 828	hematologic impairment
*	OR T52 T54 T53
T55	Condition 834 842	Pregnant
T56	Condition 846 853	nursing
T57	Person 854 861	females
*	OR T56 T55
A2	Optional T14
T58	Scope 213 421	previous therapy for more than 48 hours with any parenteral antibiotic with activity against MRSA, except vancomycin and/or daptomycin, within 72 hours of positive blood culture results confirming persistence
R18	Has_scope Arg1:T14 Arg2:T58	
